US FDA Commissioner Robert Califf Says No Formulas For Trial Diversity

The FDA does not appear likely to provide a calculation for sponsors to show clinical trial diversity, but agency officials seem split on how tough to enforce the new regulations intended to ensure all groups are adequately represented.

BIO CEO John Crowley interview FDA Commissioner Robert Califf
BIO CEO John Crowley interviews FDA Commissioner Robert Califf during a 5 June BIO 2024 session. • Source: BIO Youtube page

More from Diversity & Inclusion

More from Clinical Trials